Catherine Dowling
Catherine Dowling
Catherine Dowling is a partner in the Corporate Department specialising in Life Sciences.
Having initially trained as a solicitor in ByrneWallace LLP, Catherine has developed her career within ByrneWallace LLP, advising Irish and international clients on a wide range of corporate and commercial transactions, including private equity/venture capital, mergers and acquisitions, restructurings, and intellectual property.
Specialising in Life Sciences, Catherine has worked with a broad range of entities in the sector, from early stage university spin-out companies to publicly quoted indigenous and global pharmaceutical, biotech and medical device and diagnostic organisations.
Catherine has also advised clients on clinical trial agreements, clinical study agreements, licensing agreements, collaboration agreements, distribution agreements and various other commercial and strategic agreements.
Having initially trained as a solicitor in ByrneWallace LLP, Catherine has developed her career within ByrneWallace LLP, advising Irish and international clients on a wide range of corporate and commercial transactions, including private equity/venture capital, mergers and acquisitions, restructurings, and intellectual property.
Specialising in Life Sciences, Catherine has worked with a broad range of entities in the sector, from early stage university spin-out companies to publicly quoted indigenous and global pharmaceutical, biotech and medical device and diagnostic organisations.
Catherine has also advised clients on clinical trial agreements, clinical study agreements, licensing agreements, collaboration agreements, distribution agreements and various other commercial and strategic agreements.